Publications Database

American Society of Health-System Pharmacists (2011)

Olanzapine.

American Society of Health-System Pharmacists

Read Full (New Window)

Barnard A. L. et al. (2002)

A systematic review of the use of atypical antipsychotics in autism.

Journal of Psychopharmacology

16(1), pp. 93-101

Read Abstract (New Window)

Caccia S. (2013)

Safety and pharmacokinetics of atypical antipsychotics in children and adolescents.

Pediatric Drugs

15(3), pp. 217-233.

Read Abstract (New Window)

Chavez B. et al. (2007)

Atypical antipsychotics in children with pervasive developmental disorders.

Pediatric Drugs

9(4), pp. 249-266

Read Abstract (New Window)

Demb H. D. , Roychoudhury K. (2000)

Comments on Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study.

Journal of Clinical Psychopharmacology

20 pp. 580-581

Doyle C. A. , McDougle C. J. (2012)

Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.

Dialogues in Clinical Neuroscience

14(3), pp. 263-279.

Read Abstract (New Window) Read Full (New Window)

Elbe D. , Lalani Z. (2012)

Review of the pharmacotherapy of irritability of autism.

Journal of the Canadian Academy of Child and Adolescent Psychiatry

21(2), pp. 130-146.

Read Abstract (New Window) Read Full (New Window)

Fido A. , Al-Saad S. (2008)

Olanzapine in the treatment of behavioral problems associated with autism: an open-label trial in Kuwait.

Medical Principles and Practice

17(5), pp. 415-418

Read Abstract (New Window)

Hergüner S. , Mukaddes N. M. (2007)

Risperidone-induced enuresis in two children with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

17(4), pp. 527-530.

Read Abstract (New Window)

Hollander E. et al. (2006)

A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder

Journal of Child and Adolescent Psychopharmacology

16 pp. 541-548

Read Abstract (New Window)

Horrigan J. P. , Barnhill L. J. , Courvoisie H. E. (1997)

Olanzapine in PDD.

Journal of the American Academy of Child and Adolescent Psychiatry

Kemner C. et al. (2002)

Open-label study of olanzapine in children with pervasive developmental disorder.

Journal of Clinical Psychopharmacology

22 pp. 455-460

Read Abstract (New Window)

Malek-Ahmadi P. , Simonds J. (1998)

Olanzapine for autistic disorder with hyperactivity.

Journal of the American Academy of Child and Adolescent Psychiatry

September, 37(9), pp. 902

Read Abstract (New Window)

Malone R. P. et al. (2001)

Olanzapine versus haloperidol in children with autistic disorder: an open pilot study.

Journal of the American Academy of Child and Adolescent Psychiatry

40 pp. 887-894.

Read Abstract (New Window)

Malone R. P. , Waheed A. (2009)

The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism.

Drugs

69(5), pp. 535-548.

Read Abstract (New Window)

Masi G. (2004)

Pharmacotherapy of pervasive developmental disorders in children and adolescents.

CNS Drugs

18(14), pp. 1031-1052

Read Abstract (New Window)

Masliyah T. , Ad-Dab'bagh Y. (2011)

Low-dose risperidone-induced oculogyric crises in an adolescent male with autism, tourette's and developmental delay.

Journal of the Canadian Academy of Child and Adolescent Psychiatry

20(3), pp. 214-216

Read Abstract (New Window) Read Full (New Window)

McDougle C. J. et al. (2008)

Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.

Journal of Clinical Psychiatry

69 pp.15-20

Read Abstract (New Window)

Myers S. M. (2007)

The status of pharmacotherapy for autism spectrum disorders.

Expert Opinion on Pharmacotherapy

8(11), pp. 1579-1603

Read Abstract (New Window)

Politte L. C. , McDougle C. J. (2014)

Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders.

Psychopharmacology (Berl)

March, 231(6), pp. 1023-1036.

Read Abstract (New Window)